The global biofuel market is exploding, especially in the U.S., E.U., Brazil, and Indonesia, where there are annual record amounts of biofuel in production.
Learn how the global drive to halt the Coronavirus pandemic significantly drives digitization in pharma manufacturing.
Over the past several years, the pharmaceutical industry has deployed many Industry 4.0 strategies across a vast, complex, and sophisticated global supply chain.
In a short time, the pandemic has drastically increased our dependency on technology. Before the pandemic, pharmaceutical manufacturers had been averse to implementing new technology.
As the world is getting ready for a "Fourth Industrial Revolution," oil and gas companies looking to gain competitive advantage can benefit from automation.
Human-made carbon emissions are having a detrimental effect on the environment and, as such, have become one of the largest global environmental concerns.
Upgrading to digital twin technology offers an exciting new set of tools for industrial digital operations. Through intelligent 3D visualization of physical assets monitored by smart IoT sensors, digital twins augment engineers' toolboxes with powerful new skills, shattering the industrial status quo.
Augmented Reality: Digitized Maintenance in the Electrical Utility Industry
Undoubtedly, the pharma industry's enthusiasm for the digital revolution has snowballed in recent years. The COVID-19 pandemic, in particular, has put pharma's digital progress to the test, with the 2020 optimistic survey revealing more pharma companies are now leveraging a wide variety of digital tools to put transformation back on track.
More business decisions are driven by data these days than ever before. As companies upgrade to digitized operations, big data analytics provide critical insights to overcome challenging market conditions, which drives more significant business growth.